TEVA PHARMACEUTICAL INDS LTD (TEVA) — Hedge Fund Ownership Q1 2026
TEVA
- TEVA PHARMACEUTICAL INDS LTD (TEVA) is held by 3 of 84 tracked hedge funds, with Sound Shore Management (4%) and DME Capital Management / Greenlight Capital (3%) holding the largest stakes, indicating limited hedge fund interest relative to peers.
- The biggest decreases in TEVA holdings came from Duquesne Family Office (-60%) and Sound Shore Management (-10%), suggesting profit-taking or de-risking.
- Overall, hedge funds decreased exposure to TEVA PHARMACEUTICAL INDS LTD (TEVA) by -31% vs the prior quarter and -56% vs prior year.
| # | Fund | % of Portfolio † | Shares † | Shares vs Prior Quarter † | Shares vs Prior Year † | Aggregate Value † | Reported Price * | Option |
|---|---|---|---|---|---|---|---|---|
| 1 |
Sound Shore Management Harry Burn
|
3.92% | 3.9M | -9.84% | -28.73% | $117.0M | $30.12 | — |
| 2 |
DME Capital Management / Greenlight Capital
|
2.75% | 2.9M | -4.84% | +412.27% | $87.7M | $30.12 | — |
| 3 |
Duquesne Family Office
|
2.44% | 2.4M | -59.53% | -84.02% | $71.6M | $30.12 | — |
| 3 | Total | — | 9.2M | -30.73% | -56.11% | $276.3M | — | — |
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.